AFS_T1D · Artificial Sweetener (AFS) on Glucose Metabolism · Type 1 Diabetes (T1D)
Trial terminated
Also in this update: Primary completion date changed from estimate of Nov 1, 2025 to Sep 22, 2026; Final enrollment: 3 participants (planned 25)
McGill University Health Centre/Research Institute of the McGill University Health CentreNot specified NCT06315725 Registry history of NCT06315725 on ClinicalTrials.gov (opens the registry)